Recent Advances in Rabies Virus Genomics with Special Emphasis on Immunogenic Glycoprotein Ectodomain: Structure, Evolution, and Intervention Implications
Infectious Disease Reports · 11.11.2026 · 18 (6) · 132
DOI: 10.3390/idr18060132 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infectious Disease Reports, online erschienen am 11.11.2026. Verfasst von Richard Vijee Kennady Mervin und 13 weiteren Autor:innen. Die Arbeit nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Rabies remains an invariably fatal encephalitis claiming approximately 59,000 human lives annually, with the burden concentrated in low- and middle-income countries of Asia and Africa. Prevention depends almost exclusively upon vaccination and post-exposure prophylaxis (PEP) regimens that elicit virus-neutralizing antibodies directed against the viral glycoprotein (G). This review synthesizes recent advances in rabies virus (RABV) genomics and structural virology with particular emphasis upon the G ectodomain, the sole surface-exposed viral component and the primary immunological target of protective immunity. This review examines the RABV evolution across phylogenetically distinct lyssavirus lineages, the molecular determinants of virulence and neuroinvasiveness encoded within the G gene, and structural characterization of the ectodomain by contemporary cryo-electron microscopy and crystallography. High-resolution structural studies have resolved the quaternary organization of the prefusion trimer engaged by neutralizing antibodies, indicating that the conformational stability of these epitopes is an important determinant of vaccine-induced immunity, and cryo-electron microscopy of nine antibody complexes reported in 2026 has extended the antigenic map to six sites, two of them newly defined, unusually well conserved across lyssaviruses and recognized by the most broadly cross-reactive antibodies yet described. The applied literature is then organized around the three translational uses of the protein: its diagnostic application in ectodomain-based serology and antigen detection, its therapeutic application in monoclonal antibody cocktails replacing serum-derived immunoglobulin, and its vaccinal application across inactivated, subunit, virus-like particle, vectored, and nucleic acid platforms. Ectodomain architecture therefore underpins next-generation vaccines, improved post-exposure therapeutics and diagnostics, and with them the global target of zero human deaths from dog-mediated rabies by 2030.
Zitieren
APA
Mervin, R. V. K., Saminathan, M., Aswin, P. K., Deshmukh, S., Harne, R. S., Raja, P., Kumar, O. R. V., Joshi, V. G., Saxena, S., Kripal, S. R., Patel, C. L., Pawaiya, R. S., Singh, K. P., & Malik, Y. S. (2026). Recent Advances in Rabies Virus Genomics with Special Emphasis on Immunogenic Glycoprotein Ectodomain: Structure, Evolution, and Intervention Implications. Infectious Disease Reports, 18(6), 132. https://doi.org/10.3390/idr18060132
Vancouver
Mervin RVK, Saminathan M, Aswin PK, Deshmukh S, Harne RS, Raja P, et al. Recent Advances in Rabies Virus Genomics with Special Emphasis on Immunogenic Glycoprotein Ectodomain: Structure, Evolution, and Intervention Implications. Infectious Disease Reports. 2026;18(6):132. doi:10.3390/idr18060132
BibTeX
@article{Mervin2026,
author = {Mervin, Richard Vijee Kennady and Saminathan, Mani and Aswin, Padma Kumar and Deshmukh, Shubham and Harne, Rushikesh Suresh and Raja, Paramasivam and Kumar, Obli Rajendran Vinodh and Joshi, Vinay Ganeshrao and Saxena, Sonal and Kripal, Sudha Rani and Patel, Chabbi Lal and Pawaiya, Rajveer Singh and Singh, Karam Pal and Malik, Yashpal Singh},
title = {Recent Advances in Rabies Virus Genomics with Special Emphasis on Immunogenic Glycoprotein Ectodomain: Structure, Evolution, and Intervention Implications},
journal = {Infectious Disease Reports},
year = {2026},
volume = {18},
number = {6},
pages = {132},
doi = {10.3390/idr18060132}
}
EUVIMED